Skeletal and extraskeletal disorders of biomineralization

MT Collins, G Marcucci, HJ Anders, G Beltrami… - Nature Reviews …, 2022 - nature.com
The physiological process of biomineralization is complex and deviation from it leads to a
variety of diseases. Progress in the past 10 years has enhanced understanding of the …

SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease,'diabetic nephropathy', IgA nephropathy and podocytopathies with …

HJ Anders, AJ Peired… - Nephrology Dialysis …, 2022 - academic.oup.com
Abstract In 2020, the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney
Disease (DAPA-CKD) trial first demonstrated that inhibition of the sodium–glucose …

Only hyperuricemia with crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease

M Sellmayr, MRH Petzsche, Q Ma… - Journal of the …, 2020 - journals.lww.com
Background The roles of asymptomatic hyperuricemia or uric acid (UA) crystals in CKD
progression are unknown. Hypotheses to explain links between UA deposition and …

Gasdermin D-deficient mice are hypersensitive to acute kidney injury

W Tonnus, F Maremonti, A Belavgeni, M Latk… - Cell death & …, 2022 - nature.com
Signaling pathways of regulated necrosis, such as necroptosis and ferroptosis, contribute to
acute kidney injury (AKI), but the role of pyroptosis is unclear. Pyroptosis is mediated by the …

[HTML][HTML] p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis

Z Ye, Y **a, L Li, B Li, L Chen, W Yu, Y Ruan… - Biomedicine & …, 2023 - Elsevier
Calcium oxalate (CaOx) stones are among the most common types of kidney stones and are
associated with renal tubular damage, interstitial fibrosis, and chronic kidney disease. The …

Ferrostatin‑1 alleviates oxalate‑induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis

J **e, Z Ye, L Li, Y **a, R Yuan… - Molecular Medicine …, 2022 - spandidos-publications.com
The present study aimed to evaluate the role and mechanism of ferrostatin‑1 (Fer‑1) in
oxalate (Ox)‑induced renal tubular epithelial cell injury, fibrosis, and calcium oxalate (CaOx) …

[HTML][HTML] Sulforaphane elicts dual therapeutic effects on renal inflammatory injury and crystal deposition in calcium oxalate nephrocalcinosis

H Liu, X Yang, K Tang, T Ye, C Duan, P Lv, L Yan… - Theranostics, 2020 - ncbi.nlm.nih.gov
Intrarenal calcium oxalate (CaOx) crystals induce renal tubular epithelial cells (TECs) injury
and inflammation, which involve Toll-like receptor 4 (TLR4)/interferon regulatory factor 1 …

Interleukin-1β inhibition for chronic kidney disease in obese mice with type 2 diabetes

Y Lei, SK Devarapu, M Motrapu, CD Cohen… - Frontiers in …, 2019 - frontiersin.org
Inflammasome-driven release of interleukin (IL)-1β is a central element of many forms of
sterile inflammation and has been evident to promote the onset and progression of diabetic …

Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis

EM Buhl, S Djudjaj, BM Klinkhammer… - EMBO molecular …, 2020 - embopress.org
Kidney fibrosis is characterized by expansion and activation of platelet‐derived growth factor
receptor‐β (PDGFR‐β)‐positive mesenchymal cells. To study the consequences of PDGFR …

Soluble uric acid is an intrinsic negative regulator of monocyte activation in monosodium urate crystal–induced tissue inflammation

Q Ma, M Honarpisheh, C Li, M Sellmayr… - The Journal of …, 2020 - journals.aai.org
Although monosodium urate (MSU) crystals are known to trigger inflammation, published
data on soluble uric acid (sUA) in this context are discrepant. We hypothesized that diverse …